A little over three months after announcing a plan to cut about 17% of staff in the first half of 2025, Alector has disclosed another layoff. The San Francisco–based biotech is letting go of about 13% of its workforce, which is roughly 25 people, according to an SEC filing. The workforce reduction, once finished, will likely leave the company with just under 170 employees. According to the SEC filing, existing cash, cash equivalents and investments should fund the biotech’s operating expenses and capital expenditure requirements through 2026.
All entries for: Alector
March 26, 2025
Alector
Layoffs
South San Francisco, CA
201-500 employees
Disease Area: Immune Diseases, Multiple, Neurological Diseases, Oncology
Drug Type: Biologic